Director Ann E. Berman sold Loews Corp ($L) shares on the open market four times over the last year for a total of $618 thousand. Her most recent sale occurred on February 10, 2026. These transactions rank her 6,012th out of 11,678 insiders by sale value, well below the average of $8.6 million across about six sales per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | LOEWS CORP | $L | BERMAN ANN E | Director | A | Common Stock | 235 | $0.00 | 5,233.0000 | 209,100,000 | 4.70% | 0.00% |
| Feb. 10, 2026 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1922 | $110.16 | 4,998.0000 | 209,100,000 | 27.77% | 0.00% |
| Dec. 31, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | A | Common Stock | 234 | $0.00 | 6,920.0000 | 209,880,000 | 3.50% | 0.00% |
| Dec. 1, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $38.67 | 8,936.0000 | 209,880,000 | 33.65% | 0.00% |
| Dec. 1, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 806 | $108.13 | 8,130.0000 | 209,880,000 | 9.02% | 0.00% |
| Dec. 1, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1444 | $108.10 | 6,686.0000 | 209,880,000 | 17.76% | 0.00% |
| Dec. 1, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 209,880,000 | 100.00% | 0.00% |
| Sept. 30, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | A | Common Stock | 251 | $0.00 | 6,686.0000 | 220,530,000 | 3.90% | 0.00% |
| Sept. 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1422 | $96.67 | 6,435.0000 | 220,530,000 | 18.10% | 0.00% |
| Sept. 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $35.52 | 8,685.0000 | 220,530,000 | 34.97% | 0.00% |
| Sept. 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 220,530,000 | 100.00% | 0.00% |
| Sept. 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 828 | $96.70 | 7,857.0000 | 220,530,000 | 9.53% | 0.00% |
| June 30, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | A | Common Stock | 149 | $0.00 | 6,435.0000 | 220,530,000 | 2.37% | 0.00% |
| June 13, 2025 | Immuneering Corp | $IMRX | BERMAN ANN E | Director | A | Stock Option | 33350 | $0.00 | 33,350.0000 | 35,887,252 | 9999.99% | 0.09% |
| June 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1273 | $88.82 | 6,286.0000 | 220,530,000 | 16.84% | 0.00% |
| June 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 977 | $88.74 | 7,559.0000 | 220,530,000 | 11.45% | 0.00% |
| June 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $38.46 | 8,536.0000 | 220,530,000 | 35.79% | 0.00% |
| June 2, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 220,530,000 | 100.00% | 0.00% |
| May 14, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 1288 | $0.00 | 6,286.0000 | 220,530,000 | 25.77% | 0.00% |
| May 14, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Restricted Stock Units | 1288 | $0.00 | 0.0000 | 220,530,000 | 100.00% | 0.00% |
| March 3, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 1053 | $86.89 | 6,195.0000 | 220,530,000 | 14.53% | 0.00% |
| March 3, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1197 | $86.90 | 4,998.0000 | 220,530,000 | 19.32% | 0.00% |
| March 3, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 220,530,000 | 100.00% | 0.00% |
| March 3, 2025 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $40.61 | 7,248.0000 | 220,530,000 | 45.02% | 0.00% |
| Jan. 1, 2025 | Immuneering Corp | $IMRX | BERMAN ANN E | Director | A | Stock Option | 23485 | $0.00 | 23,485.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Immuneering Corp | $IMRX | BERMAN ANN E | Director | A | Stock Option | 17614 | $0.00 | 17,614.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 221,430,000 | 100.00% | 0.00% |
| Dec. 2, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $42.52 | 7,248.0000 | 221,430,000 | 45.02% | 0.00% |
| Dec. 2, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 1104 | $86.80 | 6,144.0000 | 221,430,000 | 15.23% | 0.00% |
| Dec. 2, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1146 | $86.48 | 4,998.0000 | 221,430,000 | 18.65% | 0.00% |
| Sept. 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 1087 | $81.38 | 4,998.0000 | 227,810,000 | 17.86% | 0.00% |
| Sept. 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $41.98 | 7,248.0000 | 227,810,000 | 45.02% | 0.00% |
| Sept. 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 1163 | $81.36 | 6,085.0000 | 227,810,000 | 16.05% | 0.00% |
| Sept. 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 227,810,000 | 100.00% | 0.00% |
| June 12, 2024 | Immuneering Corp | $IMRX | BERMAN ANN E | Director | A | Stock Option | 33350 | $0.00 | 33,350.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 1287 | $76.59 | 5,961.0000 | 227,810,000 | 17.76% | 0.00% |
| June 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $43.83 | 7,248.0000 | 227,810,000 | 45.02% | 0.00% |
| June 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 963 | $75.80 | 4,998.0000 | 227,810,000 | 16.16% | 0.00% |
| June 3, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 227,810,000 | 100.00% | 0.00% |
| May 14, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | A | Restricted Stock Units | 1288 | $0.00 | 1,288.0000 | 227,810,000 | 9999.99% | 0.00% |
| May 9, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Restricted Stock Units | 1706 | $0.00 | 0.0000 | 227,810,000 | 100.00% | 0.00% |
| May 9, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 1706 | $0.00 | 4,998.0000 | 227,810,000 | 51.82% | 0.00% |
| March 18, 2024 | Immuneering Corp | $IMRX | BERMAN ANN E | Director | P | Class A Common Stock | 57965 | $2.13 | 67,465.0000 | 0 | 610.16% | 0.00% |
| March 1, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Stock Appreciation Right | 2250 | $0.00 | 0.0000 | 227,810,000 | 100.00% | 0.00% |
| March 1, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | M | Common Stock | 2250 | $43.37 | 5,542.0000 | 227,810,000 | 68.35% | 0.00% |
| March 1, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | D | Common Stock | 1299 | $75.07 | 4,243.0000 | 227,810,000 | 23.44% | 0.00% |
| March 1, 2024 | LOEWS CORP | $L | BERMAN ANN E | Director | S | Common Stock | 951 | $75.02 | 3,292.0000 | 227,810,000 | 22.41% | 0.00% |